[
  {
    "ts": null,
    "headline": "Trump's drug price order is part request, part threat: Analyst",
    "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747092000,
      "headline": "Trump's drug price order is part request, part threat: Analyst",
      "id": 134408474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f"
    }
  },
  {
    "ts": null,
    "headline": "S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'",
    "summary": "Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.",
    "url": "https://finnhub.io/api/news?id=e47244c465885beed6f1ca595ff644dcf2ed5efc962b3620a570a6251ee670b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747081543,
      "headline": "S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'",
      "id": 134408475,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.",
      "url": "https://finnhub.io/api/news?id=e47244c465885beed6f1ca595ff644dcf2ed5efc962b3620a570a6251ee670b2"
    }
  },
  {
    "ts": null,
    "headline": "How Trump could go about executing order to slash drug prices",
    "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747079446,
      "headline": "How Trump could go about executing order to slash drug prices",
      "id": 134408480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock rises Monday, still underperforms market",
    "summary": "AbbVie Inc. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=a41842a0474b8f8650fa9f5a9ac9d5dec2af91daef3089ab92365983b12aa66c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747067460,
      "headline": "AbbVie Inc. stock rises Monday, still underperforms market",
      "id": 134402345,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=a41842a0474b8f8650fa9f5a9ac9d5dec2af91daef3089ab92365983b12aa66c"
    }
  },
  {
    "ts": null,
    "headline": "Trump expected to sign order to slash US drug prices",
    "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747061072,
      "headline": "Trump expected to sign order to slash US drug prices",
      "id": 134381623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7"
    }
  },
  {
    "ts": null,
    "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
    "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055379,
      "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
      "id": 134379227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b"
    }
  },
  {
    "ts": null,
    "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
    "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
    "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053003,
      "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
      "id": 134386076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1756275584/image_1756275584.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
      "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
    "summary": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
    "url": "https://finnhub.io/api/news?id=fbd600c371c29b6507227d096a81cc6d336a75dab9a96dd728fa103a5c6c45ae",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747044043,
      "headline": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
      "id": 134382803,
      "image": "",
      "related": "ABBV",
      "source": "DowJones",
      "summary": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
      "url": "https://finnhub.io/api/news?id=fbd600c371c29b6507227d096a81cc6d336a75dab9a96dd728fa103a5c6c45ae"
    }
  },
  {
    "ts": null,
    "headline": "The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders",
    "summary": "NEW YORK, May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=00a09237f9d229be7b489aef2ab8fbab623d4260f7d1b49330b7a046a6e303a6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747028778,
      "headline": "The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders",
      "id": 134376624,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "NEW YORK, May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=00a09237f9d229be7b489aef2ab8fbab623d4260f7d1b49330b7a046a6e303a6"
    }
  },
  {
    "ts": null,
    "headline": "SCHD: There Are Better Flight To Safety Plays Out There",
    "summary": "SCHD has been seeing renewed popularity amid this yearâs turbulent market. Read why SCHD ETF is not quite the safe haven it appears to be.",
    "url": "https://finnhub.io/api/news?id=6142a0948cebc7e4289153424982ac5bdbbea3166a97fad3e32fcb2cea38a44b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747010391,
      "headline": "SCHD: There Are Better Flight To Safety Plays Out There",
      "id": 134374697,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2190227175/image_2190227175.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "SCHD has been seeing renewed popularity amid this yearâs turbulent market. Read why SCHD ETF is not quite the safe haven it appears to be.",
      "url": "https://finnhub.io/api/news?id=6142a0948cebc7e4289153424982ac5bdbbea3166a97fad3e32fcb2cea38a44b"
    }
  }
]